Related Experiment Videos
Disseminated intravascular coagulation associated with pulmonary tuberculosis
M Fujita1, R Kunitake, Y Nagano
1Department of Internal Medicine, Nishi Fukuoka Hospital.
Internal Medicine (Tokyo, Japan)
|March 1, 1997
Summary
Disseminated intravascular coagulation (DIC), a rare complication of pulmonary tuberculosis, was observed in a patient with cavitary tuberculosis. Rifampin treatment appeared to worsen the DIC progression in this unusual case.
Area of Science:
- Pulmonology
- Hematology
- Infectious Diseases
Background:
- Pulmonary tuberculosis is an infectious disease primarily affecting the lungs.
- Disseminated intravascular coagulation (DIC) is a life-threatening condition characterized by widespread activation of coagulation.
- DIC is an exceptionally rare complication of tuberculosis.
Observation:
- A patient presented with cavitary pulmonary tuberculosis.
- The patient developed disseminated intravascular coagulation (DIC).
- The clinical course of DIC appeared to be exacerbated by Rifampin therapy.
Findings:
- This case highlights the potential, albeit rare, association between cavitary tuberculosis and DIC.
- Rifampin, a cornerstone of tuberculosis treatment, was implicated in the deterioration of DIC.
- The interplay between tuberculosis, DIC, and specific antimicrobial agents warrants further investigation.
Implications:
- Clinicians should maintain a high index of suspicion for DIC in patients with severe pulmonary tuberculosis, especially cavitary forms.
- Careful monitoring for coagulopathy is crucial during tuberculosis treatment.
- The potential adverse effect of Rifampin on DIC requires consideration in managing co-existing conditions.